{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#9 - Nolan Townsend, CEO of LEXEO Therapeutics","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/1bb785eb\"></iframe>","width":"100%","height":180,"duration":1128,"description":"Join us on the latest episode! Our Guest: Nolan Townsend, CEO of LEXEO Therapeutics\nWhat you'll get out of this episode:\nCan you tell us about your background and what led you to LEXEO?\nWhat product candidates are development at LEXEO?\nHow is what LEXEO is developing different than the current treatments in the neurological and cardiac spaces?\nAt BIO you spoke to the topic of accelerated approval, can you provide some perspective on the pathways needed for accelerated approval in gene therapy?\nHow does gene therapy address patient needs across disease areas?\nWhat's next?\n\nFull Video and more info click here: Slice Of Healthcare Website\nOur sponsors for this episode are:\nSage Growth Partners https://sage-growth.com/\nFlipMD by GoodRX https://www.goodrx.com/\nQuantum Health https://quantum-health.com/\n\nTo learn more about LEXEO Therapeutics please use the links below:\n- LEXEO TX LinkedIN - LEXEO TX Website -","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}